Meet the JCOM Author with Dr. Barkoudah: IVIG in Treating Nonventilated COVID-19 Patients With Moderate-to-Severe Hypoxia
Intravenous Immunoglobulin in Treating Nonventilated COVID-19 Patients With Moderate-to-Severe Hypoxia: A Pharmacoeconomic Analysis | JCOM Author Discussion
Dr. George Sakoulas is joined by Dr. Barkoudah to discuss his article published in the May/June 2022 issue of JCOM. His article reports on a study that demonstrates that despite high acquisition costs, IVIG is not only favorable pharmacoeconomically, but also can help preserve scarce critical care resources during COVID-19 pandemic waves when targeted to the appropriate patient population.
![](https://play.vidyard.com/o6LBgEsH8pmj8bhaJjHuvq.jpg)